Impact of calreticulin mutations on clinical and hematological phenotype and outcome in essential thrombocythemia-Reference-Cited by-同舟云学术

Impact of calreticulin mutations on clinical and hematological phenotype and outcome in essential thrombocythemia

Published:2014-03-06 Issue:10 Volume:123 Page:1552-1555
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Rotunno Giada¹,Mannarelli Carmela¹,Guglielmelli Paola¹,Pacilli Annalisa¹,Pancrazzi Alessandro¹,Pieri Lisa¹,Fanelli Tiziana¹,Bosi Alberto¹,Vannucchi Alessandro M.¹

Affiliation:

1. Department of Experimental and Clinical Medicine, University of Florence; and Azienda Ospedaliera-Universitaria Careggi, Florence, Italy

Abstract

Key Points CALR mutations occur in half of JAK2 and MPL wt patients with ET and associate with some distinctive phenotypic traits. Patients with ET harboring CALR mutations are at significantly lower risk of thrombosis compared with JAK2- and MPL-mutated patients.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/123/10/1552/1374595/1552.pdf

Reference24 articles.

1. Clinical implications of the JAK2 V617F mutation in essential thrombocythemia.;Antonioli;Leukemia,2005

2. Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study.;Campbell;Lancet,2005

3. JAK2 mutation in essential thrombocythaemia: clinical associations and long-term prognostic relevance.;Wolanskyj;Br J Haematol,2005

4. The JAK2(V617F) tyrosine kinase mutation in myelofibrosis with myeloid metaplasia: lineage specificity and clinical correlates.;Tefferi;Br J Haematol,2005

5. JAK2 V617F mutational status predicts progression to large splenomegaly and leukemic transformation in primary myelofibrosis.;Barosi;Blood,2007

Cited by 344 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical utility of investigations in triple‐negative thrombocytosis: A real‐world, multicentre evaluation of UK practice;British Journal of Haematology;2024-07-14

2. Национальные клинические рекомендации по диагностике и лечению Ph-негативных миелопролиферативных новообразований (истинной полицитемии, эссенциальной тромбоцитемии, первичного миелофиброза) (редакция 2024 г.);Clinical Oncohematology;2024-07-01

3. Myeloproliferative neoplasms in the adolescent and young adult population: A comprehensive review of the literature;British Journal of Haematology;2024-06-10

4. Central Retinal Vein Occlusion as the Debut of a Chronic Myeloproliferative Neoplasm;Ural Medical Journal;2024-05-10

5. CALR mutation burden in essential thrombocythemia and disease outcome;Blood;2024-03-28